Showing results (531-540 of 826) with videos related to
Sort By:
Pageof 83
Pharmacological Reviews|April 16, 2010
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discoveryTerry Kenakin, Laurence J MillerPharmacological Reviews|April 30, 2010
Beyond desensitization: physiological relevance of arrestin-dependent signalingLouis M Luttrell, Diane Gesty-PalmerPharmacological Reviews|November 30, 2006
International Union of Pharmacology. LX. Retinoic acid receptorsPierre Germain, Pierre Chambon, Gregor Eichele, et al.Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsLiliane Michalik, Johan Auwerx, Joel P Berger, et al.Pharmacological Reviews|June 6, 2009
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyRichard D Ye, François Boulay, Ji Ming Wang, et al.Pharmacological Reviews|May 29, 2009
Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancerLuke A J O'Neill, Clare E Bryant, Sarah L DoylePharmacological Reviews|June 25, 2009
Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward systemNatsuko Tsujino, Takeshi SakuraiPharmacological Reviews|November 17, 2010
International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and functionHelen R Kirby, Janet J Maguire, William H Colledge, et al.Pharmacological Reviews|November 17, 2010
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclatureJerold Chun, Timothy Hla, Kevin R Lynch, et al.Pharmacological Reviews|March 15, 2013
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonistsMartin C Michel, Carolyn Foster, Hans R Brunner, et al.Pageof 83